Skip to main content
Fig. 5 | Journal for ImmunoTherapy of Cancer

Fig. 5

From: Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function

Fig. 5

Spatial and temporal dynamics of immune checkpoint (IC) molecule expression on Treg during cancer progression. a Schedule for establishing the TC-1 lung adenocarcinoma model and tumor formation at each time point. b Representative plots showing CD25 and Foxp3 expression in CD4+ T cells (left) and changes at different time points after TC-1 TM tumor cell injection (right). c Representative plots of Treg (left) and summary of the proportion of Foxp3+ cells among CD4+ T cells (right) in peripheral blood (PB), spleen (SP), and lung (LG). d Levels of PD-1, TIM-3, TIGIT, and CTLA-4 expression on Foxp3+CD4+ Treg in PB, SP, and LG. e Levels of PD-1, TIM-3, TIGIT, and CTLA-4 expression on Treg and Tconv in different tissues (PB, SP, and LG). f Changes in the levels of PD-1, TIM-3, TIGIT, and CTLA-4 expression on Treg at different time points. Data are representative of three independent experiments (n = 5 mice per group in each experiment). ns, not significant; *P < 0.05, **P < 0.01, ***P < 0.001 (Student’s t-test)

Back to article page